Skip to content

Drug interactions

Ixazomib + Tucatinib

Severity: Minor

Ixazomib and Tucatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4 and may raise ixazomib levels. Ixazomib labeling does not require dose adjustment for CYP3A inhibitors, so the clinical effect is likely modest.

What this interaction means in plain words

Ixazomib and Tucatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ixazomib belongs to Oncology; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

Tucatinib inhibits CYP3A4, reducing ixazomib metabolism, although CYP3A contributes only partly to ixazomib clearance at clinical concentrations.

What to do

No dose change is required; monitor for ixazomib toxicities such as thrombocytopenia, diarrhea and neuropathy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ixazomib and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ixazomib with Tucatinib?

MediHelp rates the interaction as minor. Ixazomib and Tucatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tucatinib inhibits CYP3A4 and may raise ixazomib levels. Ixazomib labeling does not require dose adjustment for CYP3A inhibitors, so the clinical effect is likely modest.

How serious is the interaction between Ixazomib and Tucatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is required; monitor for ixazomib toxicities such as thrombocytopenia, diarrhea and neuropathy.

What other medicines interact with Ixazomib?

MediHelp also lists interactions of Ixazomib with, for example, Apalutamide, Carbamazepine, Dabrafenib. The full list is on the Ixazomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in